Literature DB >> 20211694

Changes in purines concentration in the cerebrospinal fluid of patients experiencing pain: a case-control study.

André P Schmidt1, Ana Elisa Böhmer, Félix A Soares, Irimar P Posso, Sheila B Machado, Florentino F Mendes, Luis Valmor C Portela, Diogo O Souza.   

Abstract

This study analyzes the relationship between extracellular purines and pain perception in humans. Cerebrospinal fluid (CSF) levels of purines and their metabolites were compared between patients displaying acute and/or chronic pain syndromes and control subjects. The CSF levels of IMP, inosine, guanosine and uric acid were significantly increased in the chronic pain group and correlated with pain severity (P<0.05). Patients displaying both chronic and acute pain presented similar changes in the CSF purines concentration (P<0.05). However, in the acute pain group, only CSF inosine and uric acid levels were significantly increased (P<0.05). These findings suggest that purines, in special inosine, guanosine and uric acid, are associated with the spinal mechanisms underlying nociception. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20211694     DOI: 10.1016/j.neulet.2010.02.067

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  Changes in Purines Concentration in the Cerebrospinal Fluid of Pregnant Women Experiencing Pain During Active Labor.

Authors:  André P Schmidt; Ana E Böhmer; Gisele Hansel; Félix A Soares; Jean P Oses; Alex T Giordani; Irimar P Posso; José Otávio C Auler; Florentino F Mendes; Elaine A Félix; Luís V Portela; Diogo O Souza
Journal:  Neurochem Res       Date:  2015-09-25       Impact factor: 3.996

2.  Neuroprotective effects of guanosine administration on behavioral, brain activity, neurochemical and redox parameters in a rat model of chronic hepatic encephalopathy.

Authors:  L G Paniz; M E Calcagnotto; P Pandolfo; D G Machado; G F Santos; G Hansel; R F Almeida; R S Bruch; L M Brum; F V Torres; A M de Assis; E P Rico; D O Souza
Journal:  Metab Brain Dis       Date:  2014-05-01       Impact factor: 3.584

Review 3.  Guanosine: a Neuromodulator with Therapeutic Potential in Brain Disorders.

Authors:  Débora Lanznaster; Tharine Dal-Cim; Tetsadê C B Piermartiri; Carla I Tasca
Journal:  Aging Dis       Date:  2016-10-01       Impact factor: 6.745

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.